Drug Research
Sinopharm signs with Bangladesh to jointly produce COVID-19 vaccines
Chinese pharmaceutical giant Sinopharm has signed an agreement with Bangladesh over the co-production of COVID-19 inactivated vaccines. Five million vaccines will be finished and dispensed monthly in the Bangladeshi capital Dhaka if everything goes to plan.
The chairman of Sinopharm,...
Drug Research
Seagen and RemeGen enter up to $2.6bn deal for cancer drug
Seagen and a Chinese company, RemeGen, have signed an exclusive global licencing agreement to develop and market a new HER2-targeted antibody-drug conjugate (ADC), disitamab vedotin.
Merging Seagen’s drug-linker technology with RemeGen’s new HER2 antibody, disitamab vedotin selectively carries the anti-cancer...
Drug Research
Heraeus completes multi-million Euro cancer therapy API capacity expansion
Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany.
Heraeus, a business line of Heraeus Precious Metals, is the leading global market supplier...
Drug Research
Next Generation Automation Lab Achieves Huge Productivity Gains
Eli Lilly and Company and their industry partners, including sample management specialists – Ziath, are speeding the discovery of new medicines through the fully automated Lilly Life Sciences Studio (L2S2) lab in San Diego, USA.
L2S2 was set up as...
Drug Research
Takeda and Frazier Healthcare Announce Collaboration to Launch HilleVax to Develop Clinical Stage Norovirus Vaccine Candidate
Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and commercialize Takeda’s norovirus vaccine candidate. Takeda has granted a license to HilleVax for the exclusive development and...
Drug Research
GSK and Vir Biotechnology announce Joint Procurement Agreement with European Commission for COVID-19 treatment, sotrovimab
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of sotrovimab, an investigational single dose SARS-CoV-2 monoclonal antibody for the treatment of adults and...
Drug Research
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., announced they generated potent, binding antibodies to an undisclosed oncology target for Twist’s internal pipeline...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read